Notably, GPX4 cKO CD8+ T cells failed to completely eradicate tumors (Figure 1, M and N) with fewer tumor-infiltrating transferred CD8+IFN-γ+ cells (Figure 1O) compared with control CD8+ T cells. The gene discussed is GPX4; the disease is neoplasm.